Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia. (Q44893943)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Jane A Freeman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kyle R Crassini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Cecily J Forsyth

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Naomi J Mackinlay

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Ping Han

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

William Stevenson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Stephen P Mulligan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

1 reference

8 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

99-104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

Disease-specific complications of chronic lymphocytic leukemia

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.706285

Clinical uses of intravenous immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.706285

Use of intravenous immunoglobulin in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.706285

Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.706285

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.706285

Infections in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.706285

Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.706285

Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.706285

21 January 2018

How I treat CLL up front

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.706285

Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.706285

Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.706285

Vaccination against infections in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.706285

10.3109/10428194.2012.706285

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22738394%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference